Blood Screening Market Analysis by Size, Share, Growth Opportunities and Trends 2021 – 2024
The Blood Screening Market report provides a detailed evaluation of the industry by highlighting information on different aspects which include drivers, restraints, growth opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing. It also provides a detailed analysis of global market size, regional and country-level market size, competitive landscape, impact of domestic market players and value chain optimization. Furthermore, it sheds light on the market contribution, recent developments and successful marketing strategies of leading companies.
Market Insights
Global Blood Screening Market is anticipated to reach USD 3.9 billion by 2024. It is anticipated to grow at a healthy rate in the years to come. Blood is a living tissue made up of liquid, with several proteins and cells suspended in it. It contains red blood cells, circulating fluid, platelets, and white blood cells. It offers nutrition and oxygen to the body cells through arteries, capillaries, and veins. It also helps in removal of carbon dioxide and metabolic waste from the body. Blood screening implies medical procedure wherein blood is inspected for a specific condition or disease. It helps to monitor health issues & diseases and a chronic ailments such as cancer and infections.
Request a Sample Copy
of Blood Screening Market Report @ https://www.millioninsights.com/industry-reports/blood-screening-market/request-sample
The facts that propel
the growth of the Market include surge in adoption of nucleic acid amplification
test (NAT), increase in prevalence of infectious diseases, rise in awareness
regarding healthcare, and increase in the number of blood donations.
Furthermore, surge in healthcare expenditure, increase in healthcare
initiatives by government, and technical developments in blood screening
technologies have resulted in the market growth.
On the other hand,
factors such as dearth of skilled manpower, high operating costs, and strict
regulatory approvals may hinder the market development. The introduction of
pathogen reduction technology and microbiology screening & multiplexing are
anticipated to offer profitable opportunities for the blood screening market.
and grow at a significant CAGR of 10.2% in the upcoming period as the scope,
product types, and its applications are increasing across the globe.
Blood
Screening Technology Outlook (Market Revenue in USD Million, 2013 - 2024)
•
Nucleic Acid Amplification Test (NAT)
•
ELISA
•
Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
• Next-Generation Sequencing (NGS)
• Western Blotting
Blood
Screening Product Outlook (Market Revenue in USD Million, 2013 - 2024)
•
Reagent
• Instrument
Some of the key players that fuel the growth of the Blood Screening Market include Becton, Danaher Corporation, Abbott Laboratories, Bio-Rad Laboratories, Inc., Beckman Coulter, Inc, F. Hoffmann-La Roche Ltd, Grifols, Dickinson and Company, Ortho Clinical Diagnostics, Siemens AG, and Thermo Fisher Scientific Inc. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.
Access Blood Screening
Market Report with TOC @ https://www.millioninsights.com/industry-reports/blood-screening-market
Blood Screening Regional Outlook (Market Revenue in USD Million, 2013 -
2024)
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Middle East and Africa
• South Africa
Comments
Post a Comment